CCP
MRNA icon

Carmel Capital Partners’s Moderna MRNA Stock Holding History

Carmel Capital Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11
Closed -$1.14K – 482
2023
Q3 		$1.14K Hold
11
– – ﹤0.01% 665
2023
Q2 		$1.34K Hold
11
– – ﹤0.01% 385
2023
Q1 		$1.69K Buy
+11
New +$1.81K ﹤0.01% 417

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Carmel Capital Partners's MRNA Position: Q4 2023 in Review

Carmel Capital Partners sold out of Moderna (MRNA) in Q4 2023, closing a stake of 11 shares — an estimated $1.14K sold.

Carmel Capital Partners first reported a position in MRNA in Q1 2023 and held it in 3 quarters. The position peaked at $1.69K in Q1 2023. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Carmel Capital Partners reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Carmel Capital Partners sold 11 Moderna shares in Q4 2023, an estimated $1.14K.
  • Carmel Capital Partners first reported a position in Moderna in Q1 2023 and held it in 3 quarters.
  • Carmel Capital Partners's Moderna position peaked at $1.69K in Q1 2023.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Carmel Capital Partners's 13F filing for Q4 2023, filed 1 Feb 2024.